C
씨엑스아이
900120KOSDAQ54.5 / 100
Reference Date: 2026-09-08
Financial Score13.0 / 40
News Sentiment12.5 / 25
Momentum17.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 29.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
CXI focuses on the production and sales of health foods in China, capitalizing on the rapidly growing Chinese health food market. While the market shows significant growth potential, challenges such as insufficient R&D investment, over-advertising, and counterfeit products remain notable issues.
Number of Employees
—
Average Salary
—
Score Calculation Basis
Detailed Financial Score
PER
264.05Industry Average 15.000.0Point
17.6x industry avg (risky)
PBR
6.67Industry Average 1.200.0Point
5.6x industry avg (risky)
ROE
2.56Industry Average 8.001.0Point
Well below industry avg
Debt Ratio
0.11Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20254.0 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼10.6% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲60.8% (2-year basis)
ROE Trend
1.0 / 4
Avg ROE 3.7% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position8.0Point
Near 52w high (80%, uptrend)
Current 1,040Won52-week high 1,20952-week low 352
1-month return6.0Point
1m +29.19% (strong rise)
Volume trend3.0Point
Volume flat
Detailed Disclosure
14 totalPositive 1Neutral 13Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-31
- Neutral주식등의대량보유상황보고서(일반)2026-08-31
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-31
- Neutral주식등의대량보유상황보고서(약식)2026-08-31
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-31